Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 71Carcinoma, Non-Small-Cell Lung 69Multiple Myeloma 55Prostatic Neoplasms 54Colorectal Neoplasms 42Leukemia, Myeloid, Acute 39Neoplasms 38Melanoma 34Lymphoma 33Ovarian Neoplasms 30Lymphoma, Non-Hodgkin 29Lung Neoplasms 28Squamous Cell Carcinoma of Head and Neck 27Sarcoma 27Neoplasm Metastasis 25Carcinoma, Hepatocellular 24Pancreatic Neoplasms 23Endometrial Neoplasms 23Glioma 22Carcinoma, Renal Cell 22Lymphoma, Large B-Cell, Diffuse 21Hodgkin Disease 21Recurrence 20Leukemia, Lymphocytic, Chronic, B-Cell 20Head and Neck Neoplasms 20Urinary Bladder Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Myelodysplastic Syndromes 18Esophageal Neoplasms 17Hematologic Neoplasms 16

Interventions

fludarabine 1aldesleukin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Adenosquamous × 30 days × Clear all
NCT02133196 2026-06-05

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
85 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Neoplasm Metastasis, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡